Neutra's MMJ subsidiary forms joint venture to market, develop cannabis delivery systems

NewsGuard 100/100 Score

In a major step forward in its plans to deliver healthier, more effective innovations to the fast-growing medical marijuana (MMJ) industry in the U.S., Neutra Corp. (OTCBB: NTRR) announced today that its MMJ subsidiary, Cannabis Technologies, Inc., has formed a new joint venture with Field of View Technologies, LLC, to market and develop breakthrough cannabis delivery systems.

“But this is only the beginning. We have very aggressive growth goals for 2013, and we're already working on additional partnerships that will help us capture a large share of this emerging industry.”

Smoke-free cannabinoid delivery systems have exploded in popularity with medical marijuana (MMJ) users in recent years, with vaporizers, throat sprays, oral capsules, edibles and other innovations replacing pipes and cigarettes altogether for many patients. These breakthroughs deliver the same therapeutic effects of the drug without the potential dangers and restrictions associated with smoking.

Los Angeles-based Field of View Technologies is a cutting-edge leader in the development of new cannabinoid delivery systems. Through their joint venture, NTRR will assist in marketing these new MMJ alternatives and continuing to develop new and better solutions for patients in the booming $1.7 billion MMJ market nationwide.

"We're tremendously excited about our new partnership with Field of View, and we can't wait to begin working alongside them," said NTRR CEO Sydney Jim. "But this is only the beginning. We have very aggressive growth goals for 2013, and we're already working on additional partnerships that will help us capture a large share of this emerging industry."

Source:

Neutra Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cannabis use linked to higher risk of heart attacks and strokes, study warns